REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.125
Bid: 4.00
Ask: 4.25
Change: -0.25 (-5.71%)
Spread: 0.25 (6.25%)
Open: 4.375
High: 4.375
Low: 4.125
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks edge higher in cautious end to busy week

Fri, 18th Mar 2022 16:53

(Alliance News) - European equities closed slightly higher on Friday, ending a stacked week in slightly muted fashion, though stocks grew in confidence over the course of the afternoon after Chinese leader Xi Jinping condemned Russia's invasion of Ukraine.

Equities have faced two major central bank decisions this week, as well as ongoing geopolitical tensions. Recent developments concerning the latter have done little to lift hopes that a resolution is near. However, stocks still made decent gains over the course of this week.

The FTSE 100 index ended up 19.39 points, or 0.3%, at 7,404.73 on Friday. The mid-cap FTSE 250 index closed up 180.93 points, or 0.9%, at 21,156.62. The AIM All-Share index rose 9.72 points, or 1.0%, at 1,035.05.

For the week, the blue-chip index has risen 3.5%. The FTSE 250 has added 4.7% and the AIM All-Share has advanced 4.0%.

The Cboe UK 100 index ended up 0.3% at 735.70. The Cboe 250 closed up 0.6% at 18,645.88, and the Cboe Small Companies rose 0.7% at 14,773.20.

In mainland Europe, the CAC 40 stock index in Paris rose 0.1%, while the DAX 40 in Frankfurt rose 0.2%.

The FTSE 100, CAC and DAX were all lower for much of the day, but found their groove in afternoon trade.

Equities in New York were mixed at the time of the European close.

The Dow Jones Industrial Average was down 0.2%, while the S&P 500 was up 0.3% and the Nasdaq Composite advanced 1.1%.

"European and US stocks have continued to recover more of their lost ground this week, despite there being little prospect of a ceasefire, or imminent cessation of hostilities between Russia and Ukraine," CMC Markets analyst Michael Hewson commented.

"As we head into the weekend, we have retreated from the highs of the week on rising scepticism that Russia's interest in a negotiated agreement is in any way serious, although the FTSE 100 is proving to be slightly more resilient."

Chinese leader Xi Jinping said war is "in no one's interest" during a phone call Friday with Joe Biden in which the US president aimed to pressure Beijing into joining Western condemnation of Russia's invasion of Ukraine.

The 1:50 hour-long phone call ended at 1453 GMT in Washington, the White House said.

State broadcaster CCTV reported Xi saying during the call that "state-to-state relations cannot go to the stage of military hostilities."

China and the US should "shoulder international responsibilities," Xi was quoted as saying, as well as declaring that "peace and security are the most valued treasures of the international community."

It was not immediately clear if Xi made any direct criticism of Russian President Vladimir Putin's onslaught against Ukraine or expressed willingness to assist the US-led pressure campaign on the Kremlin.

The call came after rescue workers searched desperately for any survivors buried beneath the rubble of Mariupol's bombed-out theatre Friday, as Russia's forces pounded residential areas across Ukraine, stoking allegations of war crimes.

In the wake of the attack, US Secretary of State Antony Blinken also said it was "difficult to conclude" that Vladimir Putin's regime had not engaged in war crimes by targeting civilians.

Russia has routinely denied that it is targeting civilians, claiming without evidence that hardline Ukrainian nationalists blew up the theatre in Mariupol.

The dollar was mixed at the end of the week.

The pound rose to USD1.3178 late on Friday, from USD1.3155 at the London equities close Thursday. The euro was priced at USD1.1061, lower against USD1.1113.

Against the Japanese yen, the dollar quoted at JPY119.15 in London, up from JPY118.44. The dollar hit JPY119.39, its best level since 2016.

In London, Ted Baker shares rose 17%. Sycamore Partners Management confirmed a Sky News press report that it was in early stages of considering making a possible cash offer for the fashion retailer.

Sycamore Partners said it was considering a possible cash offer for Ted Baker but noted there was no certainty any offer would be made.

In response, Ted Baker confirmed that it had not received any approach from Sycamore. Further, the retailer said it was confident in its independent prospects and would evaluate any offer against the shareholder value creation which it believes can be delivered as a standalone company.

In a positive read-across, Mulberry rose 8.5%.

AJ Bell analyst Russ Mould commented: "It looks like someone might bring an end to Ted Baker's horrific time as a listed company. US private equity group Sycamore is weighing up an offer, perhaps drawn to the fact the clothing retailer’s share price had halved between September 2021 and February this year.

"Ted Baker's fortunes have collapsed in recent years. First came the hugging incident where founder Ray Kelvin was accused of inappropriate behaviour towards staff. Then the company was besieged by a series of profit warnings, a new chief executive who lasted less than a year, and accounting errors where it overstated the value of its inventory. It was forced to slash prices to compete in a heavily discounted market, which really hurt profit margins. Sycamore appears to have spotted an opportunity to step in and buy the company while its valuation remains low and to help with the recovery efforts."

JD Wetherspoon overcame share price weakness in early trade to close up 1.9%.

It reported a narrowed interim loss, but the pub chain is yet to return to the business seen in pre-pandemic times.

Revenue for the half-year that ended January 23 came in at GBP807.4 million, nearly double the GBP431.1 million posted a year before. However, sales remain below the GBP933.0 million achieved two years ago, a pre-pandemic period.

The company posted a pretax loss of GBP21.3 million, narrowed from GBP46.2 million a year ago, but the bottom line remains far off the profit of GBP57.9 million registered two years ago.

On AIM, Simigon shares more than doubled to 3.52 pence from 1.55p on Thursday. The Israel-based software company on Thursday said Gal Erez, a 4% shareholder in the company, eventually backed the firm's acquisition by Power Breezer Sub and Maxify Solutions.

Erez withdrew a restraining order against the firm's merger and share cancellation. The last day of trading of Simigon shares will now be next week Friday. The company agreed to a USD8.5 million takeover back in Janaury.

Genedrive shares more than doubled to 33p from 16.25p on Thursday. The Manchester-based molecular diagnostics company said six installations of its MT-RNR1 Antibiotic Induced Hearing Loss system have been deployed to the Manchester University NHS Foundation Trust.

The system screens infants for a genetic mutation which can cause lifelong hearing loss if carriers are given antibiotics.

"MFT will become the first NHS trust to implement the technology into routine clinical care," Genedrive said.

Brent oil was quoted at USD107.51 a barrel at the London equities close on Friday, up from USD106.62 on Thursday. Gold stood at USD1,938.46 an ounce, lower against USD1,942.97.

Monday's UK corporate calendar has annual results from photobooth operator Photo-Me International PLC, while recruiter SThree posts a trading statement.

The economic events calendar has the latest interest rate announcement from the People's Bank of China overnight, before producer price data from Germany at 0700 GMT. Financial markets in Japan are closed to mark Vernal Equinox Day.

The week picks up pace with UK inflation data on Wednesday, and a deluge of flash PMIs on Thursday.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
29 Dec 2022 21:58

IN BRIEF: Genedrive shareholders vote down pre-emption rights power

Genedrive PLC - Manchester-based molecular diagnostics company - Reports that 21% of its shareholders voted against resolution 3 for the reappointment Tom Lindsay as a director at its annual general meeting on Thursday. 32% of its shareholders voted against resolution 5 for the reappointment of David Budd as a director, and 25% of shareholders voted against resolution 6 for the reappointment of Ian Gilham as a director. Adds that 25% of shareholders voted against resolution 10, to authorise the directors to allot equity securities in the capital.

Read more
22 Dec 2022 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 December 
Plexus Holdings PLCAGM
Wildcat Petroleum PLCAGM
Monday 26 December 
no events scheduled 
Tuesday 27 December 
Zambeef Products PLCAGM
Wednesday 28 December 
Evrima PLCAGM
Greencare Capital PLCGM re proposed name change
Lift Global Ventures PLCGM re proposed expansion within the energy sector
Thursday 29 December 
Amte Power PLCAGM
ADVFN PLCAGM
Genedrive PLCAGM
Hotel Chocolat Group PLCAGM
Lekoil LtdEGM re proposed settlement and name change
Online Blockchain PLCAGM
PetroNeft Resources PLCAGM
SkinBioTherapeutics PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:19

Genedrive shares slump as loss widens on lack of Covid-19 revenue

(Alliance News) - Genedrive PLC on Monday reported a substantially widened pretax loss as revenue slumped due to a lack of Covid-19 revenue.

Read more
21 Nov 2022 11:15

AIM WINNERS & LOSERS: Real Good Food secures turnaround funds

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
14 Nov 2022 14:32

UK earnings, trading statements calendar - next 7 days

Tuesday 15 November 
AdEPT Technology Group PLCHalf Year Results
BAE Systems PLCTrading Statement
Gear4Music PLCHalf Year Results
Imperial Brands PLCFull Year Results
Land Securities Group PLCHalf Year Results
Melrose Industries PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
R&Q Insurance Holdings LtdQ1 Results
Speedy Hire PLCHalf Year Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wincanton PLCHalf Year Results
Workspace Group PLCHalf Year Results
Wednesday 16 November 
Aristocrat Leisure LtdFull Year Results
Bridgepoint Group PLCTrading Statement
British Land Co PLCHalf Year Results
Castings PLCHalf Year Results
CMC Markets PLCHalf Year Results
Enteq Technologies PLCHalf Year Results
Experian PLCHalf Year Results
Hill & Smith PLCTrading Statement
Mediclinic International PLCHalf Year Results
Nightcap PLCFull Year Results
Premier Foods PLCHalf Year Results
Renold PLCHalf Year Results
Sage Group PLCFull Year Results
Schroder Global Real Estate SecuritiesHalf Year Results
Schroder Real Estate Investment Trust LtdHalf Year Results
SSE PLCHalf Year Results
Thursday 17 November 
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
Fuller, Smith & Turner PLCHalf Year Results
Grainger PLCFull Year Results
Great Portland Estates PLCHalf Year Results
Halma PLCHalf Year Results
Integrated Diagnostics Holdings PLCQ3 Results
Intermediate Capital Group PLCHalf Year Results
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Keller Group PLCTrading Statement
Kier Group PLCTrading Statement
Mitie Group PLCHalf Year Results
Pershing Square Holdings LtdQ3 Results
Redcentric PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tyman PLCTrading Statement
Virgin Money UK PLCFull Year Results
Zytronic PLCFull Year Results
Friday 18 November 
Bank of Cyprus Holdings PLCQ3 Results
Liontrust Asset Management PLCHalf Year Results
Monday 21 November 
Big Yellow Group PLCHalf Year Results
Compass Group PLCFull Year Results
Dialight PLCTrading Statement
Diploma PLCFull Year Results
Equipmake Holdings PLCFull Year Results
Genedrive PLCFull Year Results
Molten Ventures PLCHalf Year Results
MTI Wireless Edge LtdQ3 Results
NextEnergy Solar Fund LtdHalf Year Results
Polar Capital Holdings PLCHalf Year Results
Sirius Real Estate LtdHalf Year Results
SysGroup PLCHalf Year Results
Virgin Money UK PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
5 Oct 2022 11:40

Genedrive shares surge as pre-submission for MT-RNR1 filed to FDA

(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US.

Read more
5 Oct 2022 11:03

Genedrive engages with US FDA over infant test

(Sharecast News) - Near-patient molecular diagnostics company Genedrive has started engaging with the US Food and Drug Administration (FDA), it announced on Wednesday, to progress the regulatory approval of its 'MT-RNR1 ID Kit' into the United States.

Read more
26 Sep 2022 14:24

Genedrive says its "world first" test has been accelerated by NICE

(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence.

Read more
26 Sep 2022 14:10

Genedrive test to go through new, faster NICE process

(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.

Read more
22 Aug 2022 11:48

Genedrive's CYP2C19 ID Kit included in UK's NICE assessment

(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment.

Read more
22 Aug 2022 10:39

Another Genedrive test to be assessed by NICE

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 Jun 2022 14:42

Genedrive test to be evaluated by NICE

(Sharecast News) - Molecular diagnostics company Genedrive announced on Thursday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of the Genedrive MT-RNR1 test, via its Diagnostics Assessment Programme (DAP).

Read more
30 May 2022 18:14

IN BRIEF: Genedrive Covid-19 test receives CTDA approval in UK

Genedrive PLC - Manchester-based molecular diagnostics company - Says the UK Medicines & Healthcare Products Regulatory Agency has granted a coronavirus test device approval enabling the sale of the Genedrive COV19-ID Kit in the UK. Genedrive's application for approval was made on December 21.

Read more
29 Mar 2022 17:05

TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.